"Capital Cardiology Associates is a benchmark cardiology practice committed to improving our patients' quality of life. By providing state of the art diagnostics, board certified physicians and a caring and competent staff, we offer the highest quality of care in a comfortable, supportive atmosphere."

During the past decade, Capital Cardiology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Cardiology Associates" #1 collaborator was "Integrium" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Capital Cardiology Associates" are "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Combined Hyperlipidemia" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Capital Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Capital Cardiology Associates" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Fenofibrate" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Cardiology Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Capital Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Capital Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".